![]() Helix BioPharma Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47. | ![]() Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 2005 | Founding Date 1995 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Sassari, IT HQ Tramariglio, IT | Locations Richmond Hill, CA HQ | Locations Shanghai, CN HQ |
Employees | Employees 8 | Employees 7 | Employees 2,578 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥466.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $305k (FY, 2025) | Gross profit ¥2b (FY, 2025) |
Net income | Net income N/A | Net income ($5.2m) (FY, 2025) | Net income (¥1b) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 53k | Total funding raised $ 11.1m | Total funding raised N/A |

Helix BioPharma is a biopharmaceutical company developing therapies in the field of immuno-oncology, based on its technological platform DOS47.
View company
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company